We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3231:TSENomura Real Estate Holdings, Inc. Analysis

Data as of 2026-07-23 - not real-time

NT$173.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Wistron trades at TWD 173.5, just below the identified resistance of TWD 179.5 and comfortably above the support of TWD 139, with the 20‑day SMA (151.98) sitting below the 50‑day SMA (154.49) and both above the 200‑day SMA (142.82), indicating a neutral but slightly bullish bias. Technical momentum is supportive – the RSI sits at 66.8, the MACD histogram is positive (2.21) and the signal line is bearish, producing a bullish MACD reading, while volume trends upward and the Fear & Greed Index registers “Extreme Greed” at 91.7. Market sentiment therefore leans toward a short‑term upside of roughly 19 % toward the analyst mean target of TWD 206.9.
Fundamentally, the stock appears undervalued relative to its sector, with a trailing PE of 18.3 versus the industry average of 33.7 and a forward PE of 9.7, suggesting earnings expansion ahead. The dividend yield of 3.35 % and a modest 40 % payout ratio add income appeal, yet the company wrestles with negative operating and free cash flow and a very high debt‑to‑equity ratio of 167, raising concerns about financial flexibility. Balancing attractive valuation and yield against leverage and cash‑flow weakness frames the investment case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram and rising volume
  • Price near resistance with limited upside in the near term
  • High leverage and negative cash flow

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued PE and forward PE versus industry
  • Attractive dividend yield and reasonable payout ratio
  • Technical bullishness and upside potential toward target price

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained high debt levels and cash‑flow deficits
  • Potential earnings growth reflected in forward EPS
  • Dividend income offsetting valuation risk

Key Metrics & Analysis

Financial Health

Revenue Growth144.30%
Profit Margin1.18%
P/E Ratio18.3
ROE27.22%
ROA5.37%
Debt/Equity167.38
P/B Ratio2.9
Op. Cash FlowNT$-219190771712
Free Cash FlowNT$-281941082112
Industry P/E33.7

Technical Analysis

TrendNeutral
RSI66.8
SupportNT$139.00
ResistanceNT$179.50
MA 20NT$151.98
MA 50NT$154.49
MA 200NT$142.82
MACDBullish
VolumeIncreasing
Fear & Greed Index91.71

Valuation

Target PriceNT$206.93
Upside/Downside19.27%
GradeUndervalued
TypeBlend
Dividend Yield3.35%

Risk Assessment

Beta0.94
Volatility50.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.